Post Test, Evaluation and Credit Application Form Survey

	Strongly Disagree				Strongly Agree
Explain the impact of local epidemiological trends and resistance mechanisms of Gram-negative bacteria on initial antimicrobial selection	Explain the impact of local epidemiological trends and resistance mechanisms of Gram-negative bacteria on initial antimicrobial selection Strongly Disagree	Explain the impact of local epidemiological trends and resistance mechanisms of Gram-negative bacteria on initial antimicrobial selection	Explain the impact of local epidemiological trends and resistance mechanisms of Gram-negative bacteria on initial antimicrobial selection	Explain the impact of local epidemiological trends and resistance mechanisms of Gram-negative bacteria on initial antimicrobial selection	Explain the impact of local epidemiological trends and resistance mechanisms of Gram-negative bacteria on initial antimicrobial selection Strongly Agree
Evaluate the potential role of newer and novel antimicrobial agents in targeting antimicrobial-resistant Gram-negative pathogens	Evaluate the potential role of newer and novel antimicrobial agents in targeting antimicrobial-resistant Gram-negative pathogens Strongly Disagree	Evaluate the potential role of newer and novel antimicrobial agents in targeting antimicrobial-resistant Gram-negative pathogens	Evaluate the potential role of newer and novel antimicrobial agents in targeting antimicrobial-resistant Gram-negative pathogens	Evaluate the potential role of newer and novel antimicrobial agents in targeting antimicrobial-resistant Gram-negative pathogens	Evaluate the potential role of newer and novel antimicrobial agents in targeting antimicrobial-resistant Gram-negative pathogens Strongly Agree
Apply antimicrobial stewardship strategies to improve appropriate use of antimicrobials	Apply antimicrobial stewardship strategies to improve appropriate use of antimicrobials Strongly Disagree	Apply antimicrobial stewardship strategies to improve appropriate use of antimicrobials	Apply antimicrobial stewardship strategies to improve appropriate use of antimicrobials	Apply antimicrobial stewardship strategies to improve appropriate use of antimicrobials	Apply antimicrobial stewardship strategies to improve appropriate use of antimicrobials Strongly Agree
Utilize collaborative care model to improve patient outcomes during the pandemic era	Utilize collaborative care model to improve patient outcomes during the pandemic era Strongly Disagree	Utilize collaborative care model to improve patient outcomes during the pandemic era	Utilize collaborative care model to improve patient outcomes during the pandemic era	Utilize collaborative care model to improve patient outcomes during the pandemic era	Utilize collaborative care model to improve patient outcomes during the pandemic era Strongly Agree

Strongly Disagree

Strongly Agree

Explain the impact of local epidemiological trends and resistance mechanisms of Gram-negative bacteria on initial antimicrobial selection

Explain the impact of local epidemiological trends and resistance mechanisms of Gram-negative bacteria on initial antimicrobial selection Strongly Disagree

Explain the impact of local epidemiological trends and resistance mechanisms of Gram-negative bacteria on initial antimicrobial selection

Explain the impact of local epidemiological trends and resistance mechanisms of Gram-negative bacteria on initial antimicrobial selection Strongly Agree

Evaluate the potential role of newer and novel antimicrobial agents in targeting antimicrobial-resistant Gram-negative pathogens

Evaluate the potential role of newer and novel antimicrobial agents in targeting antimicrobial-resistant Gram-negative pathogens Strongly Disagree

Evaluate the potential role of newer and novel antimicrobial agents in targeting antimicrobial-resistant Gram-negative pathogens

Evaluate the potential role of newer and novel antimicrobial agents in targeting antimicrobial-resistant Gram-negative pathogens Strongly Agree

Apply antimicrobial stewardship strategies to improve appropriate use of antimicrobials

Apply antimicrobial stewardship strategies to improve appropriate use of antimicrobials Strongly Disagree

Apply antimicrobial stewardship strategies to improve appropriate use of antimicrobials

Apply antimicrobial stewardship strategies to improve appropriate use of antimicrobials Strongly Agree

Utilize collaborative care model to improve patient outcomes during the pandemic era

Utilize collaborative care model to improve patient outcomes during the pandemic era Strongly Disagree

Utilize collaborative care model to improve patient outcomes during the pandemic era

Utilize collaborative care model to improve patient outcomes during the pandemic era Strongly Agree

	Poor				Excellent
Teaching ability	Teaching ability Poor	Teaching ability	Teaching ability	Teaching ability	Teaching ability Excellent
Knowledge and expertise in the subject	Knowledge and expertise in the subject Poor	Knowledge and expertise in the subject	Knowledge and expertise in the subject	Knowledge and expertise in the subject	Knowledge and expertise in the subject Excellent

Poor

Excellent

Teaching ability

Teaching ability Poor

Teaching ability

Teaching ability Excellent

Knowledge and expertise in the subject

Knowledge and expertise in the subject Poor

Knowledge and expertise in the subject

Knowledge and expertise in the subject Excellent

	Strongly Disagree				Strongly Agree
The content was relevant to my practice and educational needs.	The content was relevant to my practice and educational needs. Strongly Disagree	The content was relevant to my practice and educational needs.	The content was relevant to my practice and educational needs.	The content was relevant to my practice and educational needs.	The content was relevant to my practice and educational needs. Strongly Agree
Activity slides were clear and useful.	Activity slides were clear and useful. Strongly Disagree	Activity slides were clear and useful.	Activity slides were clear and useful.	Activity slides were clear and useful.	Activity slides were clear and useful. Strongly Agree
Patient Cases were valuable and increased knowledge application.	Patient Cases were valuable and increased knowledge application. Strongly Disagree	Patient Cases were valuable and increased knowledge application.	Patient Cases were valuable and increased knowledge application.	Patient Cases were valuable and increased knowledge application.	Patient Cases were valuable and increased knowledge application. Strongly Agree
I intend to make changes based on participating in this activity.	I intend to make changes based on participating in this activity. Strongly Disagree	I intend to make changes based on participating in this activity.	I intend to make changes based on participating in this activity.	I intend to make changes based on participating in this activity.	I intend to make changes based on participating in this activity. Strongly Agree
The activity was fair, balanced, and without commercial bias.	The activity was fair, balanced, and without commercial bias. Strongly Disagree	The activity was fair, balanced, and without commercial bias.	The activity was fair, balanced, and without commercial bias.	The activity was fair, balanced, and without commercial bias.	The activity was fair, balanced, and without commercial bias. Strongly Agree

Strongly Disagree

Strongly Agree

The content was relevant to my practice and educational needs.

The content was relevant to my practice and educational needs. Strongly Disagree

The content was relevant to my practice and educational needs.

The content was relevant to my practice and educational needs. Strongly Agree

Activity slides were clear and useful.

Activity slides were clear and useful. Strongly Disagree

Activity slides were clear and useful.

Activity slides were clear and useful. Strongly Agree

Patient Cases were valuable and increased knowledge application.

Patient Cases were valuable and increased knowledge application. Strongly Disagree

Patient Cases were valuable and increased knowledge application.

Patient Cases were valuable and increased knowledge application. Strongly Agree

I intend to make changes based on participating in this activity.

I intend to make changes based on participating in this activity. Strongly Disagree

I intend to make changes based on participating in this activity.

I intend to make changes based on participating in this activity. Strongly Agree

The activity was fair, balanced, and without commercial bias.

The activity was fair, balanced, and without commercial bias. Strongly Disagree

The activity was fair, balanced, and without commercial bias.

The activity was fair, balanced, and without commercial bias. Strongly Agree

Question Title

9. Your Commitment to Change: Please list changes you plan to implement based on participating in this activity (Select all that apply)

Utilize/promote the use of rapid diagnostic techniques

More frequent and/or expanded use of susceptibility testing

Revise the institutional antibiogram protocol

Greater involvement in antimicrobial stewardship efforts

Other (please specify)

Question Title

10. What are the barriers you anticipate that may impact implementation of these changes? (Select all that apply)

Lack of funding and/or time

Lack of qualified personnel

Difficulty changing institutional policies/protocols

Formulary restrictions

Other (please specify)

Question Title

11. The average number of patients you see each month with suspected HABP/VABP symptoms is:

0-1

2-5

Other (please specify)

Question Title

12. Which of the following pathogens is not included as an urgent or serious threat by the Centers for Disease Control and Prevention?

Carbapenem-resistant Enterobacteriaceae

Carbapenem-resistant Acinetobacter

Beta-lactamase-producing H. influenzae

Multidrug-resistant P. aeruginosa

Question Title

13. Risk factors for a multidrug-resistant ventilator-associated bacterial pneumonia (VABP) include all of the following except:

Prior intravenous antibiotic use within 90 days

Age <60 years

5 or more days of hospitalization

Acute renal replacement therapy prior to VABP onset

Question Title

14. Which of the following agents would be preferred for the treatment of hospital-acquired bacterial pneumonia (HABP) caused by MDR P. aeruginosa?

Ceftolozane-tazobactam

Meropenem-vaborbactam

Aztreonam plus colistin

Eravacycline

Question Title

15. Which of the following newer antimicrobials exhibits in vitro activity against metallo-beta-lactamases?

Ceftazidime-avibactam

Meropenem-vaborbactam

Cefiderocol

Delafloxacin

Question Title

16. Additional Comments?

Thank you for participating and completing this form. Please visit www.vemcomeded.com for additional educational opportunities.

Post Test, Evaluation and Credit Application Form

Question Title

1. Name

Question Title

2. NABP ID

Question Title

3. Date of Birth (in MMDD format)

Question Title

4. Email

Question Title

5. Practice Setting

Question Title

6. Please rate if the Learning Objectives were met:

Question Title

7. Please rate faculty, James S. Lewis II, PharmD, FIDSA

Question Title

8. Overall Activity Satisfaction

Question Title

9. Your Commitment to Change: Please list changes you plan to implement based on participating in this activity (Select all that apply)

Question Title

10. What are the barriers you anticipate that may impact implementation of these changes? (Select all that apply)

Question Title

11. The average number of patients you see each month with suspected HABP/VABP symptoms is:

Question Title

12. Which of the following pathogens is not included as an urgent or serious threat by the Centers for Disease Control and Prevention?

Question Title

13. Risk factors for a multidrug-resistant ventilator-associated bacterial pneumonia (VABP) include all of the following except:

Question Title

14. Which of the following agents would be preferred for the treatment of hospital-acquired bacterial pneumonia (HABP) caused by MDR P. aeruginosa?

Question Title

15. Which of the following newer antimicrobials exhibits in vitro activity against metallo-beta-lactamases?

Question Title

16. Additional Comments?